155 related articles for article (PubMed ID: 18364486)
1. Frequency of germline genomic homozygosity associated with cancer cases.
Assié G; LaFramboise T; Platzer P; Eng C
JAMA; 2008 Mar; 299(12):1437-45. PubMed ID: 18364486
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.
Hoque MO; Lee CC; Cairns P; Schoenberg M; Sidransky D
Cancer Res; 2003 May; 63(9):2216-22. PubMed ID: 12727842
[TBL] [Abstract][Full Text] [Related]
3. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
[TBL] [Abstract][Full Text] [Related]
4. Germline genomic homozygosity and cancer risk.
Denic S; Nagelkerke N; Nicholls MG
JAMA; 2008 Jul; 300(2):169-70; author reply 170. PubMed ID: 18612113
[No Abstract] [Full Text] [Related]
5. High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Rzepecka IK; Szafron L; Stys A; Bujko M; Plisiecka-Halasa J; Madry R; Osuch B; Markowska J; Bidzinski M; Kupryjanczyk J
Cancer Genet; 2012 Mar; 205(3):94-100. PubMed ID: 22469508
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma.
Weber F; Xu Y; Zhang L; Patocs A; Shen L; Platzer P; Eng C
JAMA; 2007 Jan; 297(2):187-95. PubMed ID: 17213402
[TBL] [Abstract][Full Text] [Related]
9. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
10. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
11. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
12. Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors.
Ryu B; Song J; Sohn T; Hruban RH; Kern SE
Genomics; 2001 Feb; 72(1):108-12. PubMed ID: 11247673
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
14. Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?
Szukała K; Sowińska A; Wierzbicka M; Biczysko W; Szyfter W; Szyfter K
Mutat Res; 2006 Aug; 600(1-2):67-76. PubMed ID: 16814812
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
16. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
17. Identification of rare germline copy number variations over-represented in five human cancer types.
Park RW; Kim TM; Kasif S; Park PJ
Mol Cancer; 2015 Feb; 14():25. PubMed ID: 25644941
[TBL] [Abstract][Full Text] [Related]
18. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
Jänne PA; Li C; Zhao X; Girard L; Chen TH; Minna J; Christiani DC; Johnson BE; Meyerson M
Oncogene; 2004 Apr; 23(15):2716-26. PubMed ID: 15048096
[TBL] [Abstract][Full Text] [Related]
19. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
